Merging Hope and Science in Patient Care - European Medical Journal

Merging Hope and Science in Patient Care

Rheumatology
 

The EMJ Podcast | Episode 226

This week Jonathan is joined by Isabelle Amigues, CEO and Founder of UnabridgedMD, Denver, Colorado, USA. Together, they discuss the first part of her career as an academic clinician followed by how her diagnosis of Stage IV breast cancer shaped her approach to use the best in data-driven Western medicine combined with traditional Eastern healing. 

Spotify | Apple | Amazon MusicDownload MP3 (44 mins)

Speaker bio: 

isabelle amigues headshot

Isabelle Amigues is a renowned physician who blends Western and Eastern medicine to provide a holistic approach to healing. She earned her MSc from Université Pierre et Marie Curie in Paris and her MD from Université Claude Bernard in Lyon, followed by extensive training at prestigious institutions like Memorial Sloan Kettering, Columbia University, and Mount Sinai in New York. Isabelle spent the early part of her career as an academic clinician and leader in Rheumatology at National Jewish Health in Denver. However, her personal battle with stage IV breast cancer at age 40 reshaped her perspective on medicine. 

Driven to explore complementary and Eastern practices, Isabelle now leads UnabridgedMD, where she integrates cutting-edge, data-driven Western medicine with traditional Eastern healing techniques. Her focus on the mind-body connection empowers patients and their families, with a treatment philosophy centred on “hope driven by science.” 

Timestamps:
  • 00:00 – Introduction
  • 02:02 – Isabelle’s unique hobby: rock climbing
  • 03:33 – Isabelle’s journey into rheumatology
  • 05:58 – Being diagnosed with Stage IV breast cancer
  • 14:17 – The mind-body connection
  • 20:25 – “Hope driven by science”
  • 24:25 – The benefits of holistic approaches
  • 32:29 – Psychological distress in healthcare professionals
  • 37:10 – Synovial fluid and biomarker proteins
  • 39:48 – Isabelle’s three wishes for healthcare
  • 42:37 – Outro

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.